FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2338762004> ?p ?o ?g. }

• W2338762004 abstract "Abstract It is hypothesized that similarly to multiple myeloma, also in WM there may be a continuum between IgM MGUS, smoldering (SWM) and symptomatic WM, rather than these entities being considered as separate. The very low frequency of MYD88 L265P initially reported in IgM MGUS suggested that this could be implicated in disease transformation. However, using sensitive ASO-PCR a significant proportion of patients of patients with IgM MGUS already harbors the MYD88 mutation. Thus, the molecular mechanisms driving the malignant transformation of WM remain largely unknown. Here, we used high-sensitive 8-color multidimensional flow cytometry (MFC) to detect and sort the specific B-cell clone in BM samples (N=31) from a total of 22 newly-diagnosed WM patients (8 symptomatic, 14 SWM) as well as 9 patients with IgM MGUS. The later 9 cases had negative BM biopsy, but light-chain restricted clonal B-cells (typically CD22low, CD25+, sIgM+, LAIR1-) were identified by MFC (median 1.74%, range 0.2%-7.04%). MYD88 L265P was detected on FACS-sorted (purity ≥97%) clonal B-cells from 9/9, 13/14 and 7/8 IgM MGUS, SWM and WM patients, respectively. We first compared the genomic profile of clonal B-cells through high density Cytoscan750K array. Overall, IgM MGUS, SWM and WM patients showed a median of 2, 1.5, and 3 copy number abnormalities (CNA)/case, respectively [defined by >25 consecutive imbalanced markers/segment, >100Kb genomic size and <50% overlapping variants with patient-paired control DNA (n=6), or unpaired DNA from BM normal B-cells from 20 healthy donors]. Whole chromosomal imbalances were detected in IgM MGUS (+18), SWM (+3, +12) and WM patients (+4, +12, +18, +19). Gain and deletion of chromosomal arms was also detected in the 3 disease stages: 3q+, 6q-, 8p-, 13q-, 17p-, 18q+ in IgM MGUS; 11q- in SWM; and 6q-, 17p-, 18q+, 22q- in WM. Thus, genomic imbalances typically observed in WM (3q+,6q- or 18q+) were already detectable in clonal B-cells from IgM MGUS patients. Trisomy 4 was not present, nor CNA at 4q33-34 (previously ascribed with increased susceptibility for IgM MGUS and WM). One minimal amplified region at 8q11.23 was noted in 6 of the 31 patients (19%). Median number of copy-number-neutral loss of heterozygosity (CNN-LOH) was also similar between IgM MGUS, SWM and WM (median of 3, 2, and 3 CNN-LOH/case, respectively). Of note, two IgM MGUS patients showed CNN-LOH in minimal deleted regions often detected in the aggressive forms of the disease such as 6q16.1and 6q25.3. In accordance to the genomic profiles, preliminary analysis of gene expression profiles (GEP; HumanGene 1.0ST) between FACS-sorted clonal B-cells from IgM MGUS, SWM and WM patients showed virtually no deregulated genes (SAM Excel add-in with a FDR q-value<10-5). Consequently, we grouped patients together (n=14) and compared them to normal BM B-cells from healthy donors. Moreover, taking into consideration the aberrant phenotypes of the Waldenström’s clone, a specific comparison was made between the GEP of clonal B-cells vs CD22+/CD25- normal B-cells (n=6) as well as the small subset of normal BM B-cells that display the typical CD22low/CD25+ WM phenotype (n=4). Clonal B-cells showed de-regulation of 776 genes (92 down- and 684 up-regulated) as compared to CD22+/CD25- normal B-cells. By enrichment analysis (Ingenuity Pathways), top upstream regulators such as IFNg, the B-cell receptor (BCR) complex, and the synovial apoptosis inhibitor 1 (SYVN1) were activated in clonal B-cells, while the IL1 receptor antagonist (IL1RN) was inhibited. Well-known genes such as PRDM1, CD27, IL2Rα (CD25) or TRAF3 were also up-regulated in clonal B-cells. Noteworthy, up to 27 genes over-expressed by clonal B-cells were already up-regulated in normal BM CD22low/CD25+ B-cells vs CD22+/CD25- normal B-cells. Accordingly, when compared to the CD22low/CD25+ normal B-cell counterpart, GEP of clonal B-cells was far less deregulated (185 genes being infra-expressed). In fact, genes such as IL1R2, TLR4, TNFRSF1A, IGF1R, FCER1G or TNFSF13B (target molecules of the NFKB and IL-6 pathways) were down-regulated in the WM clone vs CD22low/CD25+ normal B-cells. In summary, our results show that clonal B-cells from IgM MGUS patients already show a molecular profile that overlaps with that of WM, and suggest that the Waldenström’s clone may arise from normal CD22low/CD25+ BM B-cells. Disclosures: No relevant conflicts of interest to declare." @default.
• W2338762004 created "2016-06-24" @default.
• W2338762004 creator A5004453681 @default.
• W2338762004 creator A5008759843 @default.
• W2338762004 creator A5013709600 @default.
• W2338762004 creator A5017642310 @default.
• W2338762004 creator A5022580411 @default.
• W2338762004 creator A5024237386 @default.
• W2338762004 creator A5029159537 @default.
• W2338762004 creator A5032091177 @default.
• W2338762004 creator A5032268486 @default.
• W2338762004 creator A5033180894 @default.
• W2338762004 creator A5034728534 @default.
• W2338762004 creator A5036725271 @default.
• W2338762004 creator A5046467543 @default.
• W2338762004 creator A5047866471 @default.
• W2338762004 creator A5051937379 @default.
• W2338762004 creator A5057834186 @default.
• W2338762004 creator A5059482051 @default.
• W2338762004 creator A5059635260 @default.
• W2338762004 creator A5067074864 @default.
• W2338762004 creator A5068600380 @default.
• W2338762004 creator A5069753479 @default.
• W2338762004 creator A5079149467 @default.
• W2338762004 creator A5080587560 @default.
• W2338762004 date "2013-11-15" @default.
• W2338762004 modified "2023-10-17" @default.
• W2338762004 title "Genomic Comparison Of Clonal B-Cells In Waldenstrom Macroglobulinemia (WM) Versus IgM MGUS" @default.
• W2338762004 doi "https://doi.org/10.1182/blood.v122.21.400.400" @default.
• W2338762004 hasPublicationYear "2013" @default.
• W2338762004 type Work @default.
• W2338762004 sameAs 2338762004 @default.
• W2338762004 citedByCount "0" @default.
• W2338762004 crossrefType "journal-article" @default.
• W2338762004 hasAuthorship W2338762004A5004453681 @default.
• W2338762004 hasAuthorship W2338762004A5008759843 @default.
• W2338762004 hasAuthorship W2338762004A5013709600 @default.
• W2338762004 hasAuthorship W2338762004A5017642310 @default.
• W2338762004 hasAuthorship W2338762004A5022580411 @default.
• W2338762004 hasAuthorship W2338762004A5024237386 @default.
• W2338762004 hasAuthorship W2338762004A5029159537 @default.
• W2338762004 hasAuthorship W2338762004A5032091177 @default.
• W2338762004 hasAuthorship W2338762004A5032268486 @default.
• W2338762004 hasAuthorship W2338762004A5033180894 @default.
• W2338762004 hasAuthorship W2338762004A5034728534 @default.
• W2338762004 hasAuthorship W2338762004A5036725271 @default.
• W2338762004 hasAuthorship W2338762004A5046467543 @default.
• W2338762004 hasAuthorship W2338762004A5047866471 @default.
• W2338762004 hasAuthorship W2338762004A5051937379 @default.
• W2338762004 hasAuthorship W2338762004A5057834186 @default.
• W2338762004 hasAuthorship W2338762004A5059482051 @default.
• W2338762004 hasAuthorship W2338762004A5059635260 @default.
• W2338762004 hasAuthorship W2338762004A5067074864 @default.
• W2338762004 hasAuthorship W2338762004A5068600380 @default.
• W2338762004 hasAuthorship W2338762004A5069753479 @default.
• W2338762004 hasAuthorship W2338762004A5079149467 @default.
• W2338762004 hasAuthorship W2338762004A5080587560 @default.
• W2338762004 hasConcept C147483822 @default.
• W2338762004 hasConcept C153911025 @default.
• W2338762004 hasConcept C159654299 @default.
• W2338762004 hasConcept C203014093 @default.
• W2338762004 hasConcept C2776364478 @default.
• W2338762004 hasConcept C2776391228 @default.
• W2338762004 hasConcept C2776553844 @default.
• W2338762004 hasConcept C2779338263 @default.
• W2338762004 hasConcept C2780898057 @default.
• W2338762004 hasConcept C2781038049 @default.
• W2338762004 hasConcept C54355233 @default.
• W2338762004 hasConcept C552990157 @default.
• W2338762004 hasConcept C553184892 @default.
• W2338762004 hasConcept C67982717 @default.
• W2338762004 hasConcept C71924100 @default.
• W2338762004 hasConcept C81089528 @default.
• W2338762004 hasConcept C86803240 @default.
• W2338762004 hasConcept C90924648 @default.
• W2338762004 hasConceptScore W2338762004C147483822 @default.
• W2338762004 hasConceptScore W2338762004C153911025 @default.
• W2338762004 hasConceptScore W2338762004C159654299 @default.
• W2338762004 hasConceptScore W2338762004C203014093 @default.
• W2338762004 hasConceptScore W2338762004C2776364478 @default.
• W2338762004 hasConceptScore W2338762004C2776391228 @default.
• W2338762004 hasConceptScore W2338762004C2776553844 @default.
• W2338762004 hasConceptScore W2338762004C2779338263 @default.
• W2338762004 hasConceptScore W2338762004C2780898057 @default.
• W2338762004 hasConceptScore W2338762004C2781038049 @default.
• W2338762004 hasConceptScore W2338762004C54355233 @default.
• W2338762004 hasConceptScore W2338762004C552990157 @default.
• W2338762004 hasConceptScore W2338762004C553184892 @default.
• W2338762004 hasConceptScore W2338762004C67982717 @default.
• W2338762004 hasConceptScore W2338762004C71924100 @default.
• W2338762004 hasConceptScore W2338762004C81089528 @default.
• W2338762004 hasConceptScore W2338762004C86803240 @default.
• W2338762004 hasConceptScore W2338762004C90924648 @default.
• W2338762004 hasLocation W23387620041 @default.
• W2338762004 hasOpenAccess W2338762004 @default.
• W2338762004 hasPrimaryLocation W23387620041 @default.
• W2338762004 hasRelatedWork W2053621223 @default.
• W2338762004 hasRelatedWork W2194688567 @default.
• W2338762004 hasRelatedWork W2528004742 @default.
• W2338762004 hasRelatedWork W2528278626 @default.

• next